Legry et al. documented that rs11039155 AA carriers of LXRA had higher HDL cholesterol and a 30% decrease in risk of having the metabolic syndrome in two cohorts of French subjects [36]. The gene discussed is NR1H3; the disease is metabolic syndrome.